Copyright
©The Author(s) 2015.
World J Ophthalmol. Feb 12, 2015; 5(1): 1-15
Published online Feb 12, 2015. doi: 10.5318/wjo.v5.i1.1
Published online Feb 12, 2015. doi: 10.5318/wjo.v5.i1.1
Table 1 Staging for severity of cicatricial conjunctivitis
Staging for severity of cicatricial conjunctivitis | |
Foster Staging[7] | |
I | Subepithelial fibrosis, positive rose-bengal staining in conjunctiva, conjunctival “shrinkage” from abnormal connective tissue due to small white striae that form around the superficial vessels in substantia propria |
II | Marked foreshortening of inferior conjunctiva described by (1) 0%-25%; (2) 25%-50%; (3) 50%-75%; and (4) 75%-100% |
III | Corneal neovascularization, trichiasis, dystichiasis, keratopathy, subepithelial bands of connective tissue resulting in symblepharon (conjunctival adhesions) formation that is described by (1) 0%-25%; (2) 25%-50%; (3) 50%-75%; and (4) 75%-100% |
IV | Severe sicca syndrome, keratinization, ankyloblepharon |
Mondino Staging[134] | |
I | 0%-25% loss of inferior conjunctival fornix depth |
II | 25%-50% loss of inferior conjunctival fornix depth |
III | 50%-75% loss of inferior conjunctival fornix depth |
IV | 75%-100% loss of inferior conjunctival fornix depth |
Table 2 Conditions associated with cicatricial conjunctivitis
Trauma |
Physical trauma |
Chemical burn |
Thermal burn |
Radiation burn |
Infection |
Trachoma |
Membranous conjunctivitis |
Allergic |
Chronic atopic keratoconjunctivitis |
Mucocutaneous disease |
Erythema multiforme |
Stevens-Johnson Syndrome |
Toxic epidermal necrolysis |
Immunobullous disorders |
Mucous membrane pemphigoid |
Bullous pemphigoid |
Pemphigus vulgaris |
Paraneoplastic pemphigus |
Lichen planus |
Dermatitis herpetiformis |
Systemic lupus erythematosus |
Systemic disorders |
Rosacea |
Sjogren's syndrome |
Graft-vs-host disease |
Sarcoidosis |
Ectodermal dysplasia |
Erythroderma ichthyosiform congenital |
Drug-induced |
Systemic |
Topical |
Table 3 Diagnostic criteria for paraneoplastic pemphigus
Diagnostic criteria for paraneoplastic pemphigus | |
Anhalt et al[94] | Camisa et al[95] |
Painful mucosal and polymorphous skin erosions that involves the trunk, extremities, palms, and soles of a patient with a neoplasm Histological changes including intraepidermal acantholysis, keratinocyte necrosis, and vacuolar interface dermatitis) Direct immunofluorescence findings of IgG and complement localized to the intercellular regions of the epithelium in a linear or granular fashion at the basement membrane zone Circulating autoantibodies that bind to stratified squamous epithelium as well as simple, columnar, and transitional epithelium Immunoprecipitation studies that demonstrate the presence of autoantibodies directed against a complex of five proteins of 250, 230, 210, 190, and 170 kDa | Major criteria Polymorphous mucocutaneous eruption Concurrent internal neoplasia Specific serum immunoprecipitation pattern Minor criteria Histology demonstrating acantholysis Direct immunofluorescence demonstrating intercellular and basement membrane staining Indirect immunofluorescence staining with rat murine epithelium Diagnosis: All three major or two major and two minor required to diagnosis paraneoplastic pemphigus |
Table 4 Overview of mucous membrane pemphigoid and pseudopemphigoid as caused by the pemphigus disease
MMP | Pseudopemphigoid | ||
PNP | OPV | ||
Location | Subepidermal | Intraepidermal | Intraepidermal |
DIF | IgG/IgA/IgM/C3 | IgG/C3 | IgG/C3 |
IIF on salt-split skin | Dermal, epidermal, or combined depending on antigen | Not applicable | Not applicable |
IEM: ultrastructural location of antigen | Lamina lucida | Hemidesmosomes | Desmosomes |
Lamina densa | Desmosomal plaques | ||
Sublamina densa (anchoring fibrils) | Lamina lucida | ||
Immunoblot: determination of antigen | Bullous pemphigoid antigen 1 (Bullous Pemphigoid 230) Bullous pemphigoid antigen 2 (Bullous Pemphigoid 180, type XVII collagen) Type VII collagen (290 kDa) Laminin332, epiligrin, or laminin 5 α3β3γ2 (165, 145, 140, 105 kDa) Laminin 6 (α3) Integrin beta 4 45 kDa epithelial protein 130 kDa epithelial protein 140 kDa epithelial protein 205 kDa epithelial protein 168 kDa epithelial protein Uncein LAD-1 (97/120 kDa) | Plakin protein family: Desmoplakin I (250 kDa) Bullous pemphigoid antigen 1 (230 kDa) Desmoplakin II and envoplakin (210 kDa) Periplakin (190 kDa) Plectin (500 kDa) Desmocollin 2 (105 kDa) Desmocollin 3 α2-macroglobulin-like-1 (A2LM1, 170 kDa) Desmoglein 1 (160 kDa) Desmoglein 3 (130 kDa) | Desmoglein 1 (160 kDa) Desmoglein 3 (130 kDa) |
Increased malignancy | Yes - solid malignancies (laminin 332 subtype) | Yes - lymphoproliferative malignancies | -- |
- Citation: Huang LC, Wong JR, Alonso-Llamazares J, Nousari CH, Perez VL, Amescua G, Karp CL, Galor A. Pseudopemphigoid as caused by topical drugs and pemphigus disease. World J Ophthalmol 2015; 5(1): 1-15
- URL: https://www.wjgnet.com/2218-6239/full/v5/i1/1.htm
- DOI: https://dx.doi.org/10.5318/wjo.v5.i1.1